Background and Aims Radiofrequency ablation (RFA) is an accepted treatment for flat
Barrett's neoplasia. Less is known about RFA for esophageal squamous cell neoplasia …

Background and study aims: Endoscopic radiofrequency ablation (RFA) is an established
therapy for Barrett's esophagus. Preliminary reports, limited by low patient numbers, also …

Background Endoscopic radiofrequency ablation (RFA) is a treatment option for early
esophageal squamous cell neoplasia (ESCN); however, long-term follow-up studies are …

BACKGROUND: Radiofrequency ablation (RFA) is safe and effective for eradicating
neoplasia in Barrett's esophagus. OBJECTIVE: To evaluate RFA for eradicating early …

Esophageal cancer is the sixth most common cause of cancer death in the world [1]. Over
80% of esophageal cancers occur in developing countries [1], and in these areas, 90% of …

AIM: To report outcomes on patients undergoing radiofrequency ablation (RFA) for early
oesophageal squamous neoplasia from a National Registry. METHODS: A Prospective …

Results: A total of 13 patients (10 HGIN, three ESCC) were included. Following endoscopic
resection in nine patients, the median extent of USLs was 4 cm and 50% of circumference …

BACKGROUND & AIMS: Radiofrequency ablation (RFA) is safe and effective treatment for
flat dysplasia associated with Barrett's esophagus (BE). However, there are limited data on …

Background & Aims Barrett's esophagus (BE) with low-grade dysplasia (LGD) can progress
to high-grade dysplasia (HGD) and esophageal adenocarcinoma (EAC). Radiofrequency …

Background and Aims A prior randomized study (Surveillance versus Radiofrequency
Ablation study [SURF study]) demonstrated that radiofrequency ablation (RFA) of Barrett's …